Biotech

Beyond the Smoke Stacks: Texas Ropes in $4 Billion Pharma-Bio Investment, an Industrial Info News Alert

SUGAR LAND, TX: ...

Valens GroWorks Licensing Inspection Completed

VANCOUVER, BRITISH COLUMBIA: ...

Revive Therapeutics Engages Massachusetts General Hospital for Cystinuria Phase 2 Study

TORONTO, ONTARIO: ...

Prima BioMed Commences Recruitment for Second Cohort of Melanoma Trial

SYDNEY, AUSTRALIA: ...

Evaluation of SpeeDx''s CE-marked ResistancePlus(TM) MG test for M. genitalium published in Journal of Clinical Microbiology

SYDNEY, AUSTRALIA: ResistancePlus(TM) MG rapidly and reliably detects the disease and determines antibiotic resistance of this increasingly resistant sexually transmitted infection ...

Atossa Genetics to Present at the 9th Annual Biotech Showcase Conference on January 9, 2017

SEATTLE, WA: ...

Prima BioMed Enters New Material Transfer Agreement With CYTLIMIC

SYDNEY, AUSTRALIA: ...

Aevi Genomic Medicine Announces Completion of Enrollment for Phase 2/3 SAGA Clinical Trial of AEVI-001 (NFC-1) in mGluR+ ADHD Adolescents

PHILADELPHIA, PA: ...

Angle PLC: Notification of Interim Results and Webcast

GUILDFORD, UNITED KINGDOM: ...

Ceapro Inc. to Present at Biotech Showcase(TM) 2017

EDMONTON, ALBERTA: Presentation with live audio webcast on Monday, January 9th at 3:00 p.m. PT ...